BSE Live
Apr 20, 16:01Prev. Close
5021.30
Open Price
5059.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:59Prev. Close
5022.90
Open Price
5048.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5086.00 (170)
| Balance Sheet of Procter and Gamble Health (in Rs. Cr.) | Mar 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
| 9 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Total Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Reserves and Surplus | 520.36 | 513.11 | 726.45 | 592.61 | 683.24 | |
| Total Reserves and Surplus | 520.36 | 513.11 | 726.45 | 592.61 | 683.24 | |
| Total Shareholders Funds | 536.96 | 538.24 | 750.89 | 616.49 | 703.71 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 5.81 | 7.57 | 9.53 | 0.60 | 3.43 | |
| Long Term Provisions | 36.12 | 29.64 | 36.87 | 40.80 | 40.05 | |
| Total Non-Current Liabilities | 41.93 | 37.21 | 46.40 | 41.40 | 43.48 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 171.60 | 167.00 | 237.04 | 176.01 | 128.76 | |
| Other Current Liabilities | 36.74 | 41.67 | 48.61 | 49.56 | 108.35 | |
| Short Term Provisions | 6.97 | 10.24 | 18.25 | 10.26 | 1.86 | |
| Total Current Liabilities | 215.31 | 218.91 | 303.90 | 235.83 | 238.97 | |
| Total Capital And Liabilities | 794.20 | 794.36 | 1,101.19 | 893.72 | 986.16 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 111.03 | 125.64 | 140.78 | 109.02 | 100.84 | |
| Intangible Assets | 0.71 | 0.96 | 0.94 | 0.04 | 0.12 | |
| Capital Work-In-Progress | 10.96 | 5.89 | 32.49 | 40.60 | 39.15 | |
| Other Assets | 4.37 | 1.90 | 2.25 | 2.60 | 2.95 | |
| Fixed Assets | 127.07 | 134.39 | 176.46 | 152.26 | 143.06 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 35.06 | 33.69 | 25.32 | 19.65 | 19.91 | |
| Long Term Loans And Advances | 10.17 | 9.74 | 6.30 | 5.99 | 5.41 | |
| Other Non-Current Assets | 95.51 | 92.32 | 97.01 | 102.18 | 90.64 | |
| Total Non-Current Assets | 267.81 | 270.14 | 305.09 | 280.08 | 259.02 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 109.37 | 109.11 | 134.94 | 115.21 | 118.37 | |
| Trade Receivables | 145.40 | 85.33 | 115.71 | 83.44 | 59.43 | |
| Cash And Cash Equivalents | 188.55 | 244.36 | 440.22 | 324.53 | 468.91 | |
| Short Term Loans And Advances | 1.59 | 1.72 | 1.53 | 1.57 | 1.45 | |
| OtherCurrentAssets | 81.48 | 83.70 | 103.70 | 88.89 | 78.98 | |
| Total Current Assets | 526.39 | 524.22 | 796.10 | 613.64 | 727.14 | |
| Total Assets | 794.20 | 794.36 | 1,101.19 | 893.72 | 986.16 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 187.34 | 165.89 | 165.48 | 258.16 | 244.23 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 70.49 | 801.30 | 160.54 | 126.28 | 146.22 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 46.60 | 542.10 | 146.52 | 122.61 | 133.12 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.37 | 5.37 | 5.37 | 5.37 | 5.37 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.02.2026
Procter Gamble Standalone December 2025 Net Sales at Rs 373.86 crore, up 20.69% Y-o-Y
12.11.2025
Procter Gamble Standalone September 2025 Net Sales at Rs 324.92 crore, up 3.67% Y-o-Y
10.09.2025
Procter Gamble Standalone June 2025 Net Sales at Rs 338.74 crore, up 19.33% Y-o-Y
01.08.2025
Procter Gamble Standalone June 2025 Net Sales at Rs 338.74 crore, up 19.33% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth